PLEASANTON, CA–(Marketwired – May 14, 2015) – ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it recently shipped its 2,000,000thCoolSculpting treatment cycle.

„As demonstrated by the shipment of our 2,000,000thcycle, the physician and consumer communities have embraced CoolSculpting as a procedure that works and that continues to expand the overall aesthetic market since non-invasive fat reduction appeals to a much broader range of the population, including men,“ said Mark Foley, President and Chief Executive Officer of ZELTIQ. „We estimate that, on average, a patient receives approximately 4 cycles per treatment which would imply that we have treated roughly 500,000 patients to date. While the shipment of our 2,000,000th cycle is an incredible accomplishment for the company, our market research shows that 22 million people in US alone are interested in reducing fat noninvasively1, which would suggest that we are still in the early stages of creating and growing the non-invasive fat reduction market. Again, we are very excited about this significant achievement in the history of the Company.“